Mariam Aguas
Valencia, VC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Real-World Effectiveness of Risankizumab in Refractory Crohn's Disease: The RISANCROHN Study From the ENEIDA Registry.
Journal: Alimentary pharmacology & therapeutics
Published: March 28, 2026
Hidradenitis suppurativa in patients with inflammatory bowel disease: a national multicenter study from the GETECCU-ENEIDA Registry.
Journal: Therapeutic advances in gastroenterology
Published: October 17, 2025
Comprehensive proteomic profile in newly diagnosed patients with inflammatory bowel disease: identification of potential biomarkers.
Journal: Journal of Crohn's & colitis
Published: October 09, 2025
Cytokine Dynamics During Ustekinumab Induction as Predictors of Treatment Response in Crohn's Disease: An Observational Study.
Journal: Biomedicines
Published: September 19, 2025
Exploration of fecal microbiota in newly diagnosed patients with inflammatory bowel disease using shotgun metagenomics.
Journal: Frontiers in cellular and infection microbiology
Published: March 18, 2025
Optimizing outcomes with maintenance IV UST in highly bio-exposed patients with IBD. Efficacy and adjusted regimen in real world.
Journal: Gastroenterologia y hepatologia
Published: July 25, 2024
Natural history, immunological and genetic characteristics of preclinical inflammatory bowel disease (EARLY): study protocol for a prospective cohort study.
Journal: Therapeutic advances in gastroenterology
Published: July 24, 2024
Telemonitoring of Active Inflammatory Bowel Disease Using the App TECCU: Short-Term Results of a Multicenter Trial of GETECCU.
Journal: Journal of medical Internet research
Published: June 03, 2024
Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study).
Journal: Alimentary pharmacology & therapeutics
Published: December 14, 2023
Real-world long-term effectiveness of ustekinumab in ulcerative colitis: results from a spanish open-label cohort.
Journal: Scandinavian journal of gastroenterology
Published: November 07, 2023
Psychological burden and quality of life in newly diagnosed inflammatory bowel disease patients.
Journal: Frontiers in psychology
Published: November 06, 2023
MicroRNA and granulocyte-monocyte adsorption apheresis combotherapy after inadequate response to anti-TNF agents in ulcerative colitis.
Journal: Journal of clinical apheresis
Published: June 29, 2023
Last Updated: 09/26/2026